ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » General Practice

Top General Practice Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN MANN MD

General Practice

24,693

$1.28M

640
391 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $52

MYUNG KIL JEON M.D.

General Practice

20,745

$927K

729
487 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

33%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$45
Average prescription price

Avg: $52

DANIEL ZINICOLA M.D.

General Practice

17,385

$976K

567
387 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $52

AGAPITO FAJARDO MD

General Practice

16,580

$779K

614
429 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $52

HERMAN SCHMID MD

General Practice

16,068

$814K

503
397 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

29%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $52

EDWARD MILLER M.D.

General Practice

15,021

$805K

437
400 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $52

ROBERT VENABLE M.D.

General Practice

13,098

$673K

435
342 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $52

RICHARD GROSS MD

General Practice

11,165

$446K

565
419 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$40
Average prescription price

Avg: $52

MUIN DUGOM M.D., FACP

General Practice

9,459

$689K

302
243 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $52

SILVERIO ENOJADO MD

General Practice

7,083

$424K

198
124 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $52

CYNTHIA MCLEMORE M.D.

General Practice

6,005

$288K

399
255 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $52

KI-BONG UM M.D.

General Practice

5,649

$293K

221
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $52

ROQUE ARIAS M.D.

General Practice

3,598

$257K

133
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

31%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $52

YINNAN HWANG MD

General Practice

3,394

$184K

153
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $52

ANDREW STOCK M.D.

General Practice

3,104

$159K

309
217 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $52

PHILIP RICE MD, PHD

General Practice

2,968

$147K

83
76 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $52

ALEXANDER NEWMAN M.D.

General Practice

2,962

$191K

194
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $52

IGNACIO CABEZUDO MD

General Practice

2,846

$125K

131
81 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$44
Average prescription price

Avg: $52

WILLIAM HEETH M.D.

General Practice

2,804

$172K

104
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $52

RONALD HUFFMAN MD

General Practice

2,788

$135K

183
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $52

ANTHONY NJAPA D.O.

General Practice

2,685

$195K

128
33 are 65+

26%
patients receiving schedule two controlled substances

Avg: 8%

26%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $52

HECTOR ESTEPAN MD

General Practice

1,966

$103K

183
102 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $52

BENJAMIN FANN MD

General Practice

1,936

$143K

125
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

26%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $52

ALBERT WHITAKER MD

General Practice

1,925

$91.6K

57
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

28%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $52

WYNNE BROWN MD

General Practice

1,848

$1,248

150
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$1
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank